Tolerability of Higher Than Current Infusion Rate and Volume of the 20% Subcutaneous Immunoglobulin IgPro20 in Primary Immunodeficiency: An Open-Label Multicenter Study (HiLo)

Journal of Allergy and Clinical Immunology - United States
doi 10.1016/j.jaci.2018.12.346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search